C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2006
10/18/2006	CN1849137A Special reagent for diagnosing and treating disease based on VEFG,HER-2,PSA protein isomer
10/18/2006	CN1849071A Improved method of resistance management for transgenic crops
10/18/2006	CN1849069A Modified oligonucleotides for telomerase inhibition
10/18/2006	CN1849064A QTL 'mapping as-you-go'
10/18/2006	CN1847402A Application of polyphosphoinositide 6-3/kinase gene in plant salt resistance
10/18/2006	CN1847401A Eukaryotic expression vector of one specific target mitochondrion and its construction process and use
10/18/2006	CN1847400A Improved xylanase with high specific activity, its gene expression vector and recombinant yeast cell, and expression method
10/18/2006	CN1847399A Isolated luciferases and the use thereof
10/18/2006	CN1847398A Recombinant dust mite class-II allergen
10/18/2006	CN1847397A EHEC 0157 shiga-like toxin IIA resisting subunit monoclonal antibody 5F3 light and heavy chain variable region gene and its application
10/18/2006	CN1847396A Endogenous and non-endogenous versions of human g protein-coupled receptors
10/18/2006	CN1847395A Lefteye flounder FOLLISTATIN gene sequence and its coded protein sequence
10/18/2006	CN1847389A L-lysine producing coryneform bacteria and methods for the production of L-lysine
10/18/2006	CN1847265A Human chorionic gonadotropic hormone beta strand carboxyl terminal 37 peptide polymer and its use
10/18/2006	CN1847257A Mononucleotide polymorphism related to hypertrophic degree of central muscle of hypertrophic cardiomyopathy and its use
10/18/2006	CN1846786A Vaccins vivants recombines et adjuves
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1280419C Process for producing matter with microbe
10/18/2006	CN1280417C Human tyrosinase expression carrier and its use
10/18/2006	CN1280416C Method for improving crop economic characteristic by FCA gene RNA structural zone transgene
10/18/2006	CN1280415C Wheat disease-resistant gene Lr-L1 and its use
10/18/2006	CN1280414C Human antibody heavy chain and light chain variable region gene against SARS-Cov S antigen and polypeptide and use thereof
10/18/2006	CN1280413C Promoter for regulating and controlling lignin to synthesize relevant enzyme gene and application
10/18/2006	CN1280412C A method to produce cloned embryos and adults from cultured cells
10/18/2006	CN1280410C Cholera vibrio strain
10/18/2006	CN1280408C Self floculation hydrogen producing bacteria and its sieving method
10/18/2006	CN1280310C Fusion protein with cold proventing and curing function and its encoding gene and use
10/18/2006	CN1280309C Erythropoietin with high specific activity
10/18/2006	CN1280307C Cytotoxin T lymphocyte
10/18/2006	CN1279971C Novel method for down-regulation of amyloid
10/17/2006	USRE39355 Fusion protein with amino acid sequence of mature human insulin-like growth factor; synthesized in recombinant cell culture by host cells transformed with expression vectors; genetic engineering
10/17/2006	USRE39352 Creatine amidinohydrolase, production thereof and use thereof
10/17/2006	USRE39350 RNA binding protein and binding site useful for expression of recombinant molecules
10/17/2006	US7124068 Crystal structure of a deacetylase and inhibitors thereof
10/17/2006	US7122727 Nucleic acid molecules from wheat encoding an R1-protein, and transgenic plant cells and plants comprising the nucleic acid molecules
10/17/2006	US7122726 Inbred maize line NP2460
10/17/2006	US7122724 Cotton cultivar DP 455 BG/RR
10/17/2006	US7122723 Plant recombination proteins
10/17/2006	US7122722 Methods for producing transgenic cotton plants using chilled apical shoot tips
10/17/2006	US7122721 DNA construct of the promoter of the B. vulgaris V-ATPase subunit c linked with a heterologous gene having strong uniform constitutive activity in as many plant tissues or cell types as possible and show an even stronger activity, or are not repressed, under stress conditions
10/17/2006	US7122720 Modified DNA molecule with a nucleotide sequence which is 80% but less than 100% homologous to desired trait DNA molecules and which imparts the desired trait to plants transformed with the DNA construct
10/17/2006	US7122719 Method of imparting disease resistance to plants by reducing polyphenol oxidase activities
10/17/2006	US7122718 Modification of plant resistance to diseases and/or pests
10/17/2006	US7122717 Comprises nucleotide seqences coding cycloartenol synthase and squalene monooxygenase for transformation of plants and enhancing terpenoid biosynthesis
10/17/2006	US7122716 Enhanced plant cell transformation by addition of host genes involved in T-DNA integration
10/17/2006	US7122715 In vitro method to create circular molecules for use in transformation
10/17/2006	US7122659 Assay methods and systems
10/17/2006	US7122658 Seed-preferred regulatory elements and uses thereof
10/17/2006	US7122657 UDP-glucose aglycon-glucosytransferase
10/17/2006	US7122656 MyD88S allows activation of JNK and AP-1, whereas the NF- kappa B pathway is completely blocked; used to obtain immunosuppression (e.g., in the case of transplantation); modulation of the expression of MyD88S can regulate the cellular responses to LPS and other immunological stimuli
10/17/2006	US7122654 Hybrid; adjust vascular system permeability
10/17/2006	US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene
10/17/2006	US7122651 Nucleic acid molecules encoding opioid growth factor receptors
10/17/2006	US7122650 Comprises nucleotide sequences coding polypeptide which inactivates corticotropin-releasing factor (CRF) for use as to in treatment of anxiety and depression
10/17/2006	US7122648 Isolated nucleic acids; binding to antibody; diagnosis of muscular disorders
10/17/2006	US7122647 Preparing solid support comprising immobilized biopolymers for detecting, measuring, separating and/or assaying DNA or proteins in a sample
10/17/2006	US7122646 Multivalent and multispecific binding proteins, their manufacture and use
10/17/2006	US7122645 Detection of viable agents
10/17/2006	US7122644 Methods and compositions for inhibiting neoplastic cell growth
10/17/2006	US7122641 Methods for purifying protein
10/17/2006	US7122639 Chemokine alpha-2 antibodies
10/17/2006	US7122638 Hybridomas cell lines; viricides
10/17/2006	US7122634 With an immunoreactivity-reducing amino acid of alanine, methionine, leucine; substituting for the naturally-occurring amino acid; correcting hemophilia in a patient deficient in factor VIII or having inhibitors to factor VIII
10/17/2006	US7122630 Proteins in cell cycle regulation; cell cycle protein binds to SYK kinase
10/17/2006	US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/17/2006	US7122527 Use of antisense oligonucleotides to inhibit the expression of human Akt-1
10/17/2006	US7122520 Nucleotide sequences coding polypeptide for use in the eating disorders
10/17/2006	US7122516 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
10/17/2006	US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides
10/17/2006	US7122382 Synthesizing a protein having a label for detection and another protein having a modification for separation in a single system by the cell-free protein synthesis; separating a pair of proteins formed by the interaction between these proteins
10/17/2006	US7122378 Producing a series of sequential cross-sectional slices of a bundle of adhered linearly-aligned fibers, determining the two-dimensional coordinates of each fiber unit within a fiber alignment slice, determining the two-dimensional coordinates of each fiber unit
10/17/2006	US7122373 Human genes and gene expression products V
10/17/2006	US7122372 Peptide useful in immunomodulation
10/17/2006	US7122369 Corynebacterium, Brevibacterium; culture product
10/17/2006	US7122368 Point mutations; recombinant vectors/molecular targets; transcription factors
10/17/2006	US7122367 Can be used to transform oil crop plants
10/17/2006	US7122366 Comprises genetically engineered aspartic protease for use in food processing; improving cocoa flavoring; odors
10/17/2006	US7122363 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics
10/17/2006	US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006	US7122361 Compositions employing a novel human kinase
10/17/2006	US7122360 Polypeptides, polynucleotides and uses thereof
10/17/2006	US7122359 Active-site engineering of nucleotidylyltransferases and general enzymatic methods for the synthesis of natural and “unnatural” UDP- and TDP-nucleotide sugars
10/17/2006	US7122358 Testis-specific tubulin tyrosine-ligase-like protein, BGS42
10/17/2006	US7122355 Thermostable DNA-Polymerase (separated or inactivated), exonuclease and a primer which does not elongate at low temperatures; enhanced specificity
10/17/2006	US7122352 Expression vectors coding interleukin polypeptide for use in prevention and treatment of infections, autoimmune, and cell proliferative disease and for stimulating the proliferation of platelets; wound healing agents
10/17/2006	US7122351 Dimerized PDGF-D and materials and methods for producing it
10/17/2006	US7122350 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA Polymerase and thereby prevent the assembly of a poised transcriptional complex
10/17/2006	US7122349 Human zven proteins
10/17/2006	US7122348 Adeno-associated viral deletion rep protein comprising functional nuclear localization sequence for use delivery of gene products to preferential intracellular locations
10/17/2006	US7122347 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
10/17/2006	US7122346 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies
10/17/2006	US7122345 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122342 Protease-activated receptor PAR4 (ZCHEMR2)
10/17/2006	US7122341 Engineering of metabolic control
10/17/2006	US7122339 Method for generating diversity
10/17/2006	US7122332 Modulators of leukocyte activation, compositions and methods of use
10/17/2006	US7122331 Isoprenoid biosynthesis
10/17/2006	US7122330 Intron containing eukaryotic gene; posttranslation; glycosylation; protein folding
10/17/2006	US7122325 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders

1 ... 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 ... 4023